Literature DB >> 6247671

Selective decline in cellular immune response to varicella-zoster in the elderly.

A E Miller.   

Abstract

The incidence of herpes zoster rises markedly in the aged. We evaluated the hypothesis that cellular immunity to varicella-zoster (VZ) viral antigens may be impaired in aged subjects. We found that the lymphocyte proliferation to VZ antigen was less in older asymptomatic individuals than in normal young controls. In contrast, responses to other antigens did not differ. Antibody titers to VZ were similar in both young and old subjects. Impairment of cellular immunity to VZ, on a population basis, may contribute to the increased risk of herpes zoster in the elderly.

Mesh:

Year:  1980        PMID: 6247671     DOI: 10.1212/wnl.30.6.582

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  46 in total

1.  Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses.

Authors:  Adriana Weinberg; Ann A Lazar; Gary O Zerbe; Anthony R Hayward; Ivan S F Chan; Rupert Vessey; Jeffrey L Silber; Rob R MacGregor; Kenny Chan; Anne A Gershon; Myron J Levin
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

Review 2.  Herpes zoster and postherpetic neuralgia: past, present and future.

Authors:  Gary J Bennett; C Peter N Watson
Journal:  Pain Res Manag       Date:  2009 Jul-Aug       Impact factor: 3.037

3.  Can herpes zoster be prevented?

Authors:  M J Levin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

Review 4.  Immunosenescence revisited. Does it have any clinical significance?

Authors:  A J Voets; L R Tulner; G J Ligthart
Journal:  Drugs Aging       Date:  1997-07       Impact factor: 3.923

Review 5.  Pathogenesis of varicelloviruses in primates.

Authors:  Werner J D Ouwendijk; Georges M G M Verjans
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

6.  Chronic medical conditions as risk factors for herpes zoster.

Authors:  Riduan M Joesoef; Rafael Harpaz; Jessica Leung; Stephanie R Bialek
Journal:  Mayo Clin Proc       Date:  2012-10       Impact factor: 7.616

7.  Severe herpes zoster infection in the United Kingdom: experience in a regional infectious disease unit.

Authors:  P Bannister; B Crosse
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

8.  The significance of the determination of lymphocytes with clinical manifestation of ophthalmic zoster sine herpete.

Authors:  Tatsuya Marumoto; Yoshimune Hiratsuka; Akira Murakami
Journal:  Clin Ophthalmol       Date:  2010-07-30

9.  IE63-specific T-cell responses associate with control of subclinical varicella zoster virus reactivation in individuals with malignancies.

Authors:  G N Malavige; L T Rohanachandra; L Jones; L Crack; M Perera; N Fernando; D Guruge; G S Ogg
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

10.  Concurrent reactivation of varicella zoster virus and herpes simplex virus in an immunocompetent child.

Authors:  Hyun-Ho Park; Mu-Hyoung Lee
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.